The test, a decade in the making, is being touted by UCSD physicians as addressing "a critical diagnostic gap." ...

A blood-based test with five biomarkers shows high accuracy in distinguishing patients with early-stage pancreatic cancer ...

A Bay Area biotech company is behind a potentially groundbreaking blood test that promises to be a game-changer in cancer ...

The Food and Drug Administration has greenlit Japan-based test manufacturer Fujirebio to begin marketing its blood test for helping doctors diagnose Alzheimer's disease in some patients, clearing the ...

ST. LOUIS--(BUSINESS WIRE)--Clinicians worried about early-onset Alzheimer’s disease in patients with cognitive concerns between the ages of 50 and 55 years can now prescribe the PrecivityAD2™ blood ...

An artificial intelligence technique for detecting DNA fragments shed by tumors and circulating in a patient's blood could help clinicians more quickly identify and determine if pancreatic cancer ...

The FDA has cleared Elecsys pTau181, the first blood test for use in primary care to help rule out Alzheimer’s disease in ...

NHS hospitals are piloting a rapid 15-minute blood test to distinguish viral vs bacterial infections in children ...

Earlier this year the Food and Drug Administration approved a new human papillomavirus test that allows for self-collection of samples in a health care setting, thereby removing what many say is an ...

Galleri should have a good chance to win FDA marketing approval in early 2027. But insurance coverage and widespread adoption ...